Cancer BiologybioRxiv
Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer
C. Y. Mah, A. D. T. Nguyen, T. Niijima…·L. M. Butler
This study identifies DECR2 as a key driver of treatment resistance in advanced prostate cancer by regulating lipid metabolism and cell cycle progression.
DOI 10.1038/s41416-023-02557-8